1. Home
  2. LIDR vs PMN Comparison

LIDR vs PMN Comparison

Compare LIDR & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIDR
  • PMN
  • Stock Information
  • Founded
  • LIDR 2013
  • PMN 2004
  • Country
  • LIDR United States
  • PMN Canada
  • Employees
  • LIDR N/A
  • PMN 8
  • Industry
  • LIDR Auto Parts:O.E.M.
  • PMN Pharmaceuticals and Biotechnology
  • Sector
  • LIDR Consumer Discretionary
  • PMN Health Care
  • Exchange
  • LIDR Nasdaq
  • PMN Nasdaq
  • Market Cap
  • LIDR 14.8M
  • PMN 17.0M
  • IPO Year
  • LIDR N/A
  • PMN N/A
  • Fundamental
  • Price
  • LIDR $0.77
  • PMN $0.48
  • Analyst Decision
  • LIDR Hold
  • PMN Strong Buy
  • Analyst Count
  • LIDR 1
  • PMN 2
  • Target Price
  • LIDR N/A
  • PMN $4.50
  • AVG Volume (30 Days)
  • LIDR 463.9K
  • PMN 55.0K
  • Earning Date
  • LIDR 08-04-2025
  • PMN 05-12-2025
  • Dividend Yield
  • LIDR N/A
  • PMN N/A
  • EPS Growth
  • LIDR N/A
  • PMN N/A
  • EPS
  • LIDR N/A
  • PMN N/A
  • Revenue
  • LIDR $246,000.00
  • PMN N/A
  • Revenue This Year
  • LIDR $2,677.23
  • PMN N/A
  • Revenue Next Year
  • LIDR $409.09
  • PMN N/A
  • P/E Ratio
  • LIDR N/A
  • PMN N/A
  • Revenue Growth
  • LIDR N/A
  • PMN N/A
  • 52 Week Low
  • LIDR $0.49
  • PMN $0.47
  • 52 Week High
  • LIDR $4.30
  • PMN $2.37
  • Technical
  • Relative Strength Index (RSI)
  • LIDR 58.46
  • PMN 40.42
  • Support Level
  • LIDR $0.68
  • PMN $0.47
  • Resistance Level
  • LIDR $0.84
  • PMN $0.56
  • Average True Range (ATR)
  • LIDR 0.06
  • PMN 0.06
  • MACD
  • LIDR 0.00
  • PMN 0.00
  • Stochastic Oscillator
  • LIDR 60.70
  • PMN 5.71

About LIDR AEye Inc.

AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: